ABSORB Clinical Investigation, Cohort B

NACompletedINTERVENTIONAL
Enrollment

101

Participants

Timeline

Start Date

March 31, 2009

Primary Completion Date

October 31, 2015

Study Completion Date

March 31, 2016

Conditions
Coronary DiseaseCoronary Artery DiseaseCoronary Restenosis
Interventions
DEVICE

Bioabsorbable Everolimus Eluting Coronary Stent

Bioabsorbable drug eluting stent implantation in the treatment of coronary artery disease

Trial Locations (12)

3010

Inselspital Bern, Kardiologie, Bern

3065

St. Vincent's Hospital, Melbourne

Unknown

Monash Heart, Melbourne

Onze-Lieve VrouweZiekenhuis, Aalst

Skejby Sygehus, Aarhus

Institut Hospitalier Jacques Cartier, Massy

Catharina ZH Eindhoven, Eindhoven

Erasmus Medical Center, Rotterdam

Maasstad Ziekenhuis, Rotterdam

Auckland City Hospital, Auckland

Christchurch Hospital, Christchurch

Jagiellonian University, Krakow

Sponsors
All Listed Sponsors
lead

Abbott Medical Devices

INDUSTRY

NCT00856856 - ABSORB Clinical Investigation, Cohort B | Biotech Hunter | Biotech Hunter